Search - tctmd.com

Displaying 361 - 373 of 373

Sort: Relevancy | Date

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

News Daily News

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Yael L. Maxwell

June 05, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

Poor Responders to Statins at Risk for CAD Progression

March 11, 2015

News Conference News AHA 2014

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

November 16, 2014

News Daily News

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

April 21, 2014

News Daily News

Statins More Beneficial Before PCI Than After in ACS Patients

March 13, 2014

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

News Conference News

Different Agents Show Potential as Adjuncts to PCI

Jason Kahn

May 19, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

News Daily News

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Jason Kahn

April 11, 2011

Advertisement

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

IMPROVE-IT Published: Hotly Debated Ezetimibe Helpful When Added to Statin Therapy

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

Poor Responders to Statins at Risk for CAD Progression

Ezetimibe Proves Clinical Benefit on Top of Statin Therapy

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

Statins More Beneficial Before PCI Than After in ACS Patients

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

Different Agents Show Potential as Adjuncts to PCI

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content